You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

AMINO ACIDS Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Amino Acids patents expire, and what generic alternatives are available?

Amino Acids is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in AMINO ACIDS is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Amino Acids

A generic version of AMINO ACIDS was approved as amino acids by B BRAUN on April 13th, 2012.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMINO ACIDS?
  • What are the global sales for AMINO ACIDS?
  • What is Average Wholesale Price for AMINO ACIDS?
Summary for AMINO ACIDS
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
DailyMed Link:AMINO ACIDS at DailyMed
Drug patent expirations by year for AMINO ACIDS
Pharmacology for AMINO ACIDS
Drug ClassAmino Acid

US Patents and Regulatory Information for AMINO ACIDS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun AMINO ACIDS amino acids INJECTABLE;INJECTION 091112-001 Apr 13, 2012 RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
B Braun AMINO ACIDS amino acids INJECTABLE;INJECTION 091112-002 Apr 13, 2012 RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

AMINO ACIDS Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Amino Acids

Global Market Overview

The global amino acids market is poised for significant growth, driven by diverse and expanding applications. As of 2022, the global amino acids market was valued at US$ 25.28 billion and is expected to exhibit a compound annual growth rate (CAGR) of 8.4% from 2023 to 2030[1].

Key Drivers of Market Growth

Increasing Demand for Dietary Supplements and Functional Foods

The growing awareness of health and wellness among consumers has led to an increased demand for dietary supplements and functional foods, which are rich in amino acids. This trend is particularly prominent in regions where there is a high adoption of healthy lifestyles, such as Asia Pacific and North America[1][3].

Animal Feed Sector

The demand for amino acids in the animal feed sector is driven by the need to enhance nutritional value and prevent metabolic diseases in livestock. Countries like China and India are experiencing rapid growth in livestock production, further boosting the demand for feed amino acids like lysine[1].

Pharmaceutical and Personal Care Industries

Amino acids are increasingly used in the pharmaceutical industry for drug formulations due to their therapeutic properties. Additionally, the personal care and cosmetics industries are driving demand with the introduction of amino acid-based products, such as those announced by The Marquie Group, Inc.[1][3].

Regional Insights

Asia Pacific

Asia Pacific is expected to dominate the global amino acids market due to rapid economic growth, increasing adoption of healthy lifestyles, and strong growth in end-use sectors like pharmaceuticals, nutraceuticals, and personal care. The region's increasing livestock production, particularly in China and India, also contributes to this dominance[1].

North America

North America is the second leading region in the global amino acids market, driven by strong demand from the animal feed and nutraceutical industries. The U.S. and Canada are significant players in animal feed production, with the U.S. feed exports accounting for a substantial portion of global animal feed exports[1].

U.S. Market Specifics

The U.S. amino acids market was estimated at around USD 3.95 billion in 2023 and is projected to reach USD 8.79 billion by 2033, growing at a CAGR of 8.33% from 2024 to 2033. Key factors driving this growth include increasing consumer awareness of health and wellness, expanding applications in pharmaceuticals, and growing demand from the animal feed sector[3][4].

Technological Advancements and Sustainability

Advancements in technology are enhancing the efficiency and quality of amino acid production. There is also a growing trend towards environmentally sustainable and eco-friendly products, which is influencing the development of amino acid-based products[4].

Market Trends

Ready-to-Drink Beverages

The trend of consuming ready-to-drink beverages is influencing the demand for amino acids, particularly aspartame, which includes the amino acids phenylalanine and aspartic acid. This trend is driven by the growing working population and increasing disposable income[1].

Changing Fashion Trends in Personal Care

The growing demand for amino acids from personal care products is another significant trend. Companies are introducing premium amino acid-based products to cater to the increasing demand for health and beauty products[1].

Restraints and Challenges

Price Volatility of Raw Materials

One of the major restraints on the amino acids market is the price volatility of raw materials, which can hamper market growth and stability[1].

Role in Microbial Control and Drug Development

Amino acids play a crucial role in microbial control and drug development. They are used to develop antimicrobial peptides that are highly effective and less prone to microbial resistance. Additionally, d-amino acids are being explored as antibiofilm agents, adjuvants, and potential drug excipients[2].

Financial Trajectory

The financial trajectory of the amino acids market is robust, with significant growth projected over the next decade. The global market is expected to grow at a CAGR of 8.4% from 2023 to 2030, while the U.S. market is anticipated to grow at a CAGR of 8.33% from 2024 to 2033[1][3].

Key Takeaways

  • The global amino acids market is valued at US$ 25.28 billion as of 2022 and is expected to grow at a CAGR of 8.4% from 2023 to 2030.
  • The U.S. amino acids market is projected to reach USD 8.79 billion by 2033, growing at a CAGR of 8.33% from 2024 to 2033.
  • Key drivers include increasing demand for dietary supplements, functional foods, and animal feed, as well as growing applications in pharmaceuticals and personal care.
  • Asia Pacific and North America are leading regions in the global amino acids market.
  • Technological advancements and the trend towards sustainable products are shaping the market.

FAQs

What is the current size of the global amino acids market?

The global amino acids market was valued at US$ 25.28 billion in 2022[1].

What is the projected CAGR for the global amino acids market from 2023 to 2030?

The global amino acids market is expected to exhibit a CAGR of 8.4% from 2023 to 2030[1].

Which region is expected to dominate the global amino acids market?

Asia Pacific is expected to dominate the global amino acids market due to rapid economic growth and increasing adoption of healthy lifestyles[1].

What are the key drivers of the U.S. amino acids market?

Key drivers include increasing consumer awareness of health and wellness, expanding applications in pharmaceuticals, and growing demand from the animal feed sector[3][4].

How are amino acids used in microbial control and drug development?

Amino acids are used to develop antimicrobial peptides, and d-amino acids are explored as antibiofilm agents, adjuvants, and potential drug excipients[2].

Cited Sources:

  1. Coherent Market Insights - Amino Acid Market - Share, Size and Industry Analysis
  2. MDPI - Multimodal Role of Amino Acids in Microbial Control and Drug Development
  3. Vision Research Reports - U.S. Amino Acids Market Size to Reach USD 8.79 Bn by 2033
  4. Grand View Research - U.S. Amino Acids Market Size, Share | Industry Report, 2030

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.